Revenue of Shanghai Pharmaceuticals 2019, by segment
In 2019, SPGC generated a revenue of approximately 23.5 billion yuan from the industrial segment of the business. SPGC is a listed company in Shanghai and Hong Kong, and a leading player in the Chinese pharmaceutical market.